ANCON Medical presents to clinical experts in Lung Cancer

ANCON is proud to be invited to present at ADVANCING EARLY DETECTION OF LUNG CANCER in association with the Cleveland Clinic in Ohio, from April 30 to May 1, 2018.

The meeting brings together industry partners committed to performing excellent science in the pursuit of meaningful clinical advances in early detection of lung cancer. The conference invites clinical experts to share their perspective on what the needs of lung cancer detection are, and industry researchers to share their achievements and thoughts about the future.

Representing ANCON Medical, Dr Glyn Hiatt-Gipson PhD leads a discussion on molecular biomarker detection in screening and early-stage diagnostic. Lung cancer is precisely the kind of disease where ANCON Medical’s advanced disease screening technology can be life-saving. Non-invasive, simple to use, and affordable, the ANCON’s Nanoparticle Biomarker Tagging (NBT) technology can detect the presence of disease by measuring exhaled breath for signs of the disease.

Read the full article on ANCON Medical’s website >>


Search news

Categorized news

Read from archive

Signup to our newsletter

Ancon Technologies Company Introduction